{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:30:46Z","timestamp":1786995046608,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T00:00:00Z","timestamp":1549152000000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"US Army","award":["W81XWH-16-1-0016"],"award-info":[{"award-number":["W81XWH-16-1-0016"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.npep.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T14:32:50Z","timestamp":1510151570000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder"],"prefix":"10.1016","volume":"67","author":[{"given":"Robert","family":"Camp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles T.","family":"Stier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia I.","family":"Serova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"McCloskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Reyes-Zaragoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther L.","family":"Sabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2017.11.006_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(90)90235-2","article-title":"Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat","volume":"118","author":"Aguirre","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.11.006_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.npep.2015.11.081","article-title":"NPY overexpression in NTS induces hyperphagia and attenuates sympathetic tone","volume":"55","author":"Ailanen","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1748-1716.1986.tb07834.x","article-title":"Studies on cardiac distribution and function of neuropeptide Y","volume":"126","author":"Allen","year":"1986","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.npep.2017.11.006_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-8993(00)02285-X","article-title":"Behavioral characterization of neuropeptide Y knockout mice","volume":"868","author":"Bannon","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.11.006_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0196-9781(91)90121-5","article-title":"Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses","volume":"12","author":"Barraco","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.npep.2017.11.006_bb0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.npep.2017.11.006_bb0040","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2017.11.006_bb0045","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/npp.2012.94","article-title":"Post-exposure sleep deprivation facilitates correctly timed interactions between glucocorticoid and adrenergic systems, which attenuate traumatic stress responses","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2017.11.006_bb0050","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.npep.2017.11.006_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2016.07.022","article-title":"Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases","volume":"95","author":"Duarte-Neves","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2017.11.006_bb0060","first-page":"R865","article-title":"Decreased cardiorespiratory effects of neuropeptide Y in the nucleus tractus solitarius in diabetes","volume":"262","author":"Dunbar","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.npep.2017.11.006_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3940(83)90132-5","article-title":"Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat","volume":"43","author":"Edvinsson","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.11.006_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1476-5381.1984.tb16516.x","article-title":"Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels","volume":"83","author":"Edvinsson","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.11.006_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ynstr.2014.09.007","article-title":"Targeting the neuropeptide Y system in stress-related psychiatric disorders","volume":"1","author":"Enman","year":"2015","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.npep.2017.11.006_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1748-1716.1983.tb07261.x","article-title":"Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat","volume":"118","author":"Fuxe","year":"1983","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.npep.2017.11.006_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.npep.2015.09.010","article-title":"The role of NPY in learning and memory","volume":"55","author":"G\u00f8tzsche","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0090","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1523\/JNEUROSCI.2305-08.2008","article-title":"The role of neuropeptide Y in the expression and extinction of fear-potentiated startle","volume":"28","author":"Gutman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.npep.2017.11.006_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1990.tb01366.x","article-title":"Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses","volume":"82","author":"Heilig","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.npep.2017.11.006_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.npep.2012.10.002","article-title":"30Years of NPY research","volume":"46","author":"Herzog","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10571-011-9793-z","article-title":"NPY and stress 30 years later: the peripheral view","volume":"32","author":"Hirsch","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.npep.2017.11.006_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainres.2006.04.026","article-title":"CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder","volume":"1095","author":"Hou","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.11.006_bb0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0361-9230(97)00101-9","article-title":"Intracerebroventricular administration of NPY increases sympathetic tone selectively in vascular beds","volume":"44","author":"Hu","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.npep.2017.11.006_bb0125","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/npp.2011.317","article-title":"Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons","volume":"37","author":"Ionescu","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npep.2017.11.006_bb0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2017.11.006_bb0135","article-title":"Neuropeptide Y, resilience, and PTSD therapeutics","volume":"649","author":"Kautz","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.11.006_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0196-9781(97)00266-0","article-title":"Cardiovascular actions of neuropeptide Y and social stress","volume":"19","author":"Klemfuss","year":"1998","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/physrev.00042.2006","article-title":"Catecholaminergic systems in stress: structural and molecular genetic approaches","volume":"89","author":"Kvetnansky","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2017.11.006_bb0150","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1476-5381.1996.tb15647.x","article-title":"Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects","volume":"118","author":"Lacroix","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.11.006_bb0155","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/en.2014-1192","article-title":"Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats","volume":"155","author":"Laukova","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2017.11.006_bb0160","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/alcalc\/agu029","article-title":"Chronic ethanol consumption increases myocardial mitochondrial DNA mutations: a potential contribution by mitochondrial topoisomerases","volume":"49","author":"Laurent","year":"2014","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.npep.2017.11.006_bb0165","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.euroneuro.2016.06.004","article-title":"Traumatic stress causes distinctive effects on fear circuit catecholamines and the fear extinction profile in a rodent model of posttraumatic stress disorder","volume":"26","author":"Lin","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.npep.2017.11.006_bb0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1748-1716.1982.tb07171.x","article-title":"Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function","volume":"116","author":"Lundberg","year":"1982","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.npep.2017.11.006_bb0175","first-page":"H879","article-title":"Blood pressure increases after injection of neuropeptide Y into posterior hypothalamic nucleus","volume":"254","author":"Martin","year":"1988","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.npep.2017.11.006_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.npep.2015.10.007","article-title":"Development of neuropeptide Y-mediated heart innervation in rats","volume":"55","author":"Masliukov","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0185","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.HYP.0000066623.64368.4E","article-title":"Hypotension and reduced catecholamines in neuropeptide Y transgenic rats","volume":"41","author":"Michalkiewicz","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2017.11.006_bb0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.0000153953.69799.f2","article-title":"Central neuropeptide Y signaling ameliorates N(omega)-nitro-L-arginine methyl ester hypertension in the rat through a Y1 receptor mechanism","volume":"45","author":"Michalkiewicz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2017.11.006_bb0195","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.11.006_bb0200","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006842-200105000-00010","article-title":"Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress","volume":"63","author":"Morgan","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.npep.2017.11.006_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0006-3223(02)01319-7","article-title":"Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report","volume":"52","author":"Morgan","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2017.11.006_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/cn500342u","article-title":"A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances","volume":"6","author":"Nedelcovych","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.npep.2017.11.006_bb0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0196-9781(96)00013-7","article-title":"Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients","volume":"17","author":"Nilsson","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrn3339","article-title":"Biological studies of post-traumatic stress disorder","volume":"13","author":"Pitman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.npep.2017.11.006_bb0225","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0006-3223(99)00185-7","article-title":"Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD","volume":"47","author":"Rasmusson","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2017.11.006_bb0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: a stressful review","volume":"55","author":"Reichmann","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","article-title":"Neuropeptide Y: a stressful review","volume":"55","author":"Reichmann","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000188602","article-title":"Stress-induced hypertension and increased sympathetic activity in mice overexpressing neuropeptide Y in noradrenergic neurons","volume":"89","author":"Ruohonen","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.npep.2017.11.006_bb0245","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000150099","article-title":"Kinetics and persistence of cardiovascular and locomotor effects of immobilization stress and influence of ACTH treatment","volume":"89","author":"Sabban","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.npep.2017.11.006_bb0250","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jnc.13347","article-title":"Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y","volume":"135","author":"Sabban","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2017.11.006_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.npep.2015.11.004","article-title":"Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder","volume":"56","author":"Sabban","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.11.006_bb0260","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/mp.2012.101","article-title":"Neuropeptide Y and posttraumatic stress disorder","volume":"18","author":"Sah","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2017.11.006_bb0265","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.biopsych.2009.04.037","article-title":"Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder","volume":"66","author":"Sah","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2017.11.006_bb0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.psyneuen.2013.10.017","article-title":"Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder","volume":"40","author":"Sah","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.npep.2017.11.006_bb0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10253890600557315","article-title":"The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat","volume":"9","author":"Sajdyk","year":"2006","journal-title":"Stress"},{"key":"10.1016\/j.npep.2017.11.006_bb0280","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.expneurol.2016.06.020","article-title":"Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): a translational update","volume":"284","author":"Schmeltzer","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2017.11.006_bb0285","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuroscience.2013.01.040","article-title":"Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats","volume":"236","author":"Serova","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2017.11.006_bb0290","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.11.006_bb0295","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(95)00637-6","article-title":"Quantitative analysis of the olfactory pathway for drug delivery to the brain","volume":"692","author":"Thorne","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2017.11.006_bb0300","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.npep.2017.11.006_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.RES.64.1.55","article-title":"Cardiovascular effects of neuropeptide Y in rat brainstem nuclei","volume":"64","author":"Tseng","year":"1989","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2017.11.006_bb0310","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)23711-9","article-title":"Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action","volume":"234","author":"Wahlestedt","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.npep.2017.11.006_bb0315","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neubiorev.2016.04.018","article-title":"The brain norepinephrine system, stress and cardiovascular vulnerability","volume":"74","author":"Wood","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.npep.2017.11.006_bb0320","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","article-title":"Central functions of neuropeptide Y in mood and anxiety disorders","volume":"15","author":"Wu","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.npep.2017.11.006_bb0325","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/da.20629","article-title":"Single prolonged stress: toward an animal model of posttraumatic stress disorder","volume":"26","author":"Yamamoto","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.npep.2017.11.006_bb0330","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biopsych.2005.08.027","article-title":"Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping","volume":"59","author":"Yehuda","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.npep.2017.11.006_bb0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijcard.2016.06.138","article-title":"The role of neuropeptide Y in the pathophysiology of atherosclerotic cardiovascular disease","volume":"220","author":"Zhu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.npep.2017.11.006_bb0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-0115(86)90080-7","article-title":"Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats","volume":"15","author":"Zukowska-Grojec","year":"1986","journal-title":"Regul. Pept."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917302196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917302196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T20:34:52Z","timestamp":1758918892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417917302196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":68,"alternative-id":["S0143417917302196"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2017.11.006","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}